Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-070776
Filing Date
2011-03-18
Accepted
2011-03-18 11:23:55
Documents
9
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1031201
2 SUBSIDIARIES dex211.htm EX-21.1 2130
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1502
4 CERTIFICATION OF CMO PURSUANT OT SECTION 302 OF THE SARBANES-OXLEY ACT dex311.htm EX-31.1 5738
5 CERTIFICATION OF CFO PURSUANT OT SECTION 302 OF THE SARBANES-OXLEY ACT dex312.htm EX-31.2 5784
6 CERTIFICATION OF CMO PURSUANT OT SECTION 906 OF THE SARBANES-OXLEY ACT dex321.htm EX-32.1 3093
7 CERTIFICATION OF CFO PURSUANT OT SECTION 906 OF THE SARBANES-OXLEY ACT dex322.htm EX-32.2 3205
8 GRAPHIC g159569g63i74.jpg GRAPHIC 86723
9 GRAPHIC g159569g74n84.jpg GRAPHIC 16882
  Complete submission text file 0001193125-11-070776.txt   1196833
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34641 | Film No.: 11697317
SIC: 2834 Pharmaceutical Preparations